CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 6.5: safe zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
623.85MCAD445.20M · vs all stocks (USD)
Revenue (TTM)
66.52MCAD47.47M · vs all stocks (USD)
Profit Margin
-12.69%vs Health Information Services peers
Beta
1.35xvs all stocks
52-Week Change
10.05%vs all stocks
Market Capitalization
623.85MCAD445.20M · vs all stocks (USD)
Enterprise Value
596.26MCAD425.51M · vs all stocks (USD)
Forward P/E
323.00xvs Health Information Services peers
Price to Sales (TTM)
9.38xvs Health Information Services peers
Price to Book (MRQ)
9.85xvs Health Information Services peers
Enterprise to Revenue
8.96xvs Health Information Services peers
Enterprise to EBITDA
-64.90xvs Health Information Services peers
Gross Margin
77.52%vs Health Information Services peers
Profit Margin
-12.69%vs Health Information Services peers
Operating Margin
-12.93%vs Health Information Services peers
Return on Assets (TTM)
-4.26%vs Health Information Services peers
Return on Equity (TTM)
-12.98%vs Health Information Services peers
Revenue (TTM)
66.52MCAD47.47M · vs all stocks (USD)
Revenue per Share (TTM)
0.6980CADUpdated Jul 20, 2026Quarterly Revenue Growth
22.10%vs Health Information Services peers
Gross Profit (TTM)
50.97MCAD36.38M · vs all stocks (USD)
EBITDA (TTM)
6.06MCAD4.33M · vs all stocks (USD)
Net Income (TTM)
-8.44MCAD-6.02M · vs all stocks (USD)
Operating Cash Flow (TTM)
2.29MCAD1.63M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-18.74MCAD-13.37M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CADUpdated Jul 20, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Health Information Services peers
Revenue
63.26MCADFY2025 · Dec 31, 2025Cost of Goods Sold
15.32MCADFY2025 · Dec 31, 2025Gross Profit
47.94MCADFY2025 · Dec 31, 2025Operating Income
-8.45MCAD-6.03M · vs all stocks (USD)
Pre-tax Income
-2.19MCADFY2025 · Dec 31, 2025Income Tax Expense
158.86KCADFY2025 · Dec 31, 2025Net Income
-2.35MCADFY2025 · Dec 31, 2025EBIT
1.24MCADFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.06MCADFY2025 · Dec 31, 2025Research & Development
22.08MCADFY2025 · Dec 31, 2025Selling, General & Administrative
34.31MCADFY2025 · Dec 31, 2025Non-operating Interest Income
516.74KCADFY2025 · Dec 31, 2025Non-operating Interest Expense
3.43MCADFY2025 · Dec 31, 2025EPS (Basic)
-0.0200CADFY2025 · Dec 31, 2025EPS (Diluted)
-0.0200CADFY2025 · Dec 31, 2025Basic Shares Outstanding
94.91MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
94.91MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-2.35MCADFY2025 · Dec 31, 2025Operating Cash Flow
21.71MCADFY2025 · Dec 31, 2025Free Cash Flow
21.43MCADDerived from operating cash flow minus capital expenditure. This filing charges 13.99M of depreciation against 279.65K of capital expenditure, and its own free-cash-flow line reads -9.77M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
48.74MCADFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-2.35MCADFY2025 · Dec 31, 2025Depreciation & Amortization
13.99MCADFY2025 · Dec 31, 2025Deferred Taxes (CF)
158.86KCADFY2025 · Dec 31, 2025Stock-based Compensation
3.99MCADFY2025 · Dec 31, 2025Other Non-cash Items
3.39MCADFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
5.36MCADFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.83MCADFY2025 · Dec 31, 2025Capital Expenditures
-279.65KCADFY2025 · Dec 31, 2025Net Intangibles (CF)
-21.75MCADFY2025 · Dec 31, 2025Other Investing Activity
1.93MCADFY2025 · Dec 31, 2025Net Investing Cash Flow
1.65MCADFY2025 · Dec 31, 2025Long-term Debt Payments
-7.29MCADFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.29MCADFY2025 · Dec 31, 2025Shares Outstanding
96.13MSharesUpdated Jul 20, 2026Float Shares
75.10MSharesUpdated Jul 20, 2026Shares Short
2.85MSharesUpdated Jul 20, 2026Short Ratio
3.82daysvs all stocks
% Held by Insiders
21.78%vs all stocks
% Held by Institutions
22.62%vs all stocks
Total Cash (MRQ)
51.52MCAD36.77M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5360CADUpdated Jul 20, 2026Total Debt (MRQ)
26.77MCAD19.10M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4242xvs Health Information Services peers
Current Ratio (MRQ)
1.41xvs Health Information Services peers
Book Value per Share (MRQ)
0.6560CADUpdated Jul 20, 2026Total Assets
121.76MCAD86.89M · vs all stocks (USD)
Total Current Assets
65.64MCADFY2025 · Dec 31, 2025Total Liabilities
56.74MCADFY2025 · Dec 31, 2025Total Non-current Assets
56.12MCADFY2025 · Dec 31, 2025Total Non-current Liabilities
20.62MCADFY2025 · Dec 31, 2025Total Current Liabilities
36.12MCADFY2025 · Dec 31, 2025Cash
48.74MCADFY2025 · Dec 31, 2025Cash & Cash Equivalents
48.74MCADFY2025 · Dec 31, 2025Accounts Receivable
7.20MCADFY2025 · Dec 31, 2025Accounts Payable
540.48KCADFY2025 · Dec 31, 2025Short-term Debt
7.87MCADFY2025 · Dec 31, 2025Deferred Revenue
18.90MCADFY2025 · Dec 31, 2025Long-term Debt
20.62MCADFY2025 · Dec 31, 2025Common Stock (Book)
144.06MCADFY2025 · Dec 31, 2025Retained Earnings
-81.38MCADFY2025 · Dec 31, 2025Total Shareholders' Equity
65.02MCAD46.40M · vs all stocks (USD)
52-Week Low
3.23CADUpdated Jul 20, 202652-Week High
6.50CADUpdated Jul 20, 202652-Week Change
10.05%vs all stocks
Beta
1.35xvs all stocks
50-Day MA
5.92CADUpdated Jul 20, 2026200-Day MA
4.87CADUpdated Jul 20, 2026Avg 10-Day Volume
275.86KSharesUpdated Jul 20, 2026Avg 30-Day Volume
553.72KSharesUpdated Jul 20, 2026Diluted EPS (TTM)
-0.0800CADUpdated Jul 20, 2026Other Income / Expense
9.17MCADFY2025 · Dec 31, 20254 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Is this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
Cash Flow, Profit, and Revenue All Growing
Free cash flow and gross profit have both grown over four years, with revenue up in each of the last three.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.78Profit Margin: -0.13
Financial Health
Altman Z-Score 6.5: safe zoneNotable
Altman Z-Score: 6.50
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Emudhra Ltd.
Tier 1RuleRecurring-Revenue Lock-InInterfaceFlow
Xperi Inc.
Tier 1RuleRecurring-Revenue Lock-InInterfaceProduction
AhnLab Inc.
Tier 1RuleRecurring-Revenue Lock-InProductionRisk
Global Security Experts Inc.
Tier 1RuleRecurring-Revenue Lock-InSenseMakingProduction
Arqit Quantum Inc.
Tier 1RuleRecurring-Revenue Lock-InProductionFlow
Positive Group PJSC
Tier 1RuleRecurring-Revenue Lock-InSenseMakingProduction
Beijing Certificate Authority Co., Ltd.
Tier 1RuleRecurring-Revenue Lock-InInterfaceFlow
Donnelley Financial Solutions Inc.
Tier 1RuleRecurring-Revenue Lock-InSenseMakingFlow
Intercede Group Plc
Tier 1RuleRecurring-Revenue Lock-InInterfaceProduction
PCI-PAL plc
Tier 1RuleRecurring-Revenue Lock-InRiskFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Ozata Denizcilik Sanayi ve Ticaret A.S.
1 interpretationCash-Flow Ratios Elevated
10x Genomics Inc.
2 interpretationsFCF Ratios ElevatedCash-Flow Ratios Elevated
Happy Forgings Ltd
1 interpretationCash-Flow Ratios Elevated